Welcome to LookChem.com Sign In|Join Free
  • or
trimethyl({3,3,6,6-tetramethyl-2-[(trimethylsilyl)oxy]cyclohex-1-en-1-yl}oxy)silane is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

177263-27-3

Post Buying Request

177263-27-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

177263-27-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 177263-27-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,2,6 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 177263-27:
(8*1)+(7*7)+(6*7)+(5*2)+(4*6)+(3*3)+(2*2)+(1*7)=153
153 % 10 = 3
So 177263-27-3 is a valid CAS Registry Number.

177263-27-3Relevant academic research and scientific papers

Highly efficient separation of actinides from lanthanides by a phenanthroline-derived bis-triazine ligand

Lewis, Frank W.,Harwood, Laurence M.,Hudson, Michael J.,Drew, Michael G. B.,Desreux, Jean F.,Vidick, Geoffrey,Bouslimani, Nouri,Modolo, Giuseppe,Wilden, Andreas,Sypula, Michal,Vu, Trong-Hung,Simonin, Jean-Pierre

, p. 13093 - 13102 (2011)

The synthesis, lanthanide complexation, and solvent extraction of actinide(III) and lanthanide(III) radiotracers from nitric acid solutions by a phenanthroline-derived quadridentate bis-triazine ligand are described. The ligand separates Am(III) and Cm(II

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

-

Page/Page column 20, (2020/09/27)

The present invention relates to compounds of formula I: in which A1-A7 and R1 to R5 are defined herein, for use in the treatment of a condition or disease which is alleviated by the activation of retinoic acid receptors (RAR). The invention also relates to pharmaceutical compounds comprising such compounds, and related methods of treatment. In an aspect, the invention relates to a method of screening compounds for therapeutic potential in the treatment of a condition or disease which is alleviated by the activation of retinoic acid receptors (RAR). Aspects of the invention relate to novel compounds of formula I in which at least one of A1 to A3 is N or at least one of A4 is CR12 or A5 is CR13 in which R12/R13 is halogen.

SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION

-

Page/Page column 20-21, (2011/07/09)

The invention discloses an improved process for the preparation of 2,2,5,5-tetrasubstituted hexane-1,6-dicarbonyl compounds, and in particular diethyl 2,2,5,5-tetramethylhexanedioate and dimethyl 2,2,5,5-tetramethylhexanedioate, by the alkylation of 1,2-d

Synthesis and structure-activity relationships of 2- pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Jones, Paul,Villeneuve, Gérald B.,Fei, Chengpei,DeMarte, Josie,Haggarty, Allison J.,Nwe, Khin Than,Martin, Deborah A.,Lebuis, Anne-Marie,Finkelstein, Joshua M.,Gour-Salin, Barbara J.,Chan, Tak Hang,Leyland-Jones, Brian R.

, p. 3062 - 3077 (2007/10/03)

The structure-activity relationships of two series of novel retinoids (2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates) have been investigated by evaluating their ability to induce differentiation in both human promyelocytic leukemia (H

On the homoconjugation between donor and acceptor fragments. Synthesis and properties of bishomosquaric acid derivatives

Gleiter, Rolf,Doerner, Thomas,Irngartinger, Hermann

, p. 381 - 391 (2007/10/03)

The tetraketone 3,3,6,6-tetramethylcyclohexane-1,2,4,5-tetrone (11) and its congener bicyclo[3.2.2]nonane-6,7,8,9-tetrone (17) were synthesized by conventional procedures. The photoreaction of 11 and 17 with tetramethylethylene yields 3,3,4,4,7,7,10,10-oc

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 177263-27-3